Home › Conditions › Gut › Crohn's Disease
Digestive Condition

Crohn's Disease
Chronic Gut Inflammation That Needs a Clear Diagnosis

Crohn's disease is a chronic inflammatory bowel disease that can affect any part of the gastrointestinal tract, from the mouth to the anus. It is most commonly found in the terminal ileum and colon, but its defining characteristic is that it can appear anywhere, skip between segments, and involve the full thickness of the gut wall. The incidence in India is rising, and many patients go years without a correct diagnosis, often labelled as IBS or stressed. Understanding what Crohn's actually is, what drives it, and how it behaves over time matters enormously for getting it right and avoiding the complications that untreated disease produces.

Take Gut Assessment
Dr. Chhavi Bansal BHMS, Gut Health Specialist HomeoSure
Quick Answer

Crohn's disease is a chronic immune-mediated inflammatory condition affecting the gastrointestinal tract. Unlike ulcerative colitis, which is confined to the colon, Crohn's can affect any GI segment. Inflammation in Crohn's is patchy (skip lesions) and transmural (through the full thickness of the gut wall), which creates a risk for complications not seen in IBS: strictures (narrowing), fistulas (abnormal connections between organs), abscesses, and perianal disease. Diagnosis requires ileocolonoscopy with biopsy, often with MRI enterography for small bowel assessment. Active Crohn's is treatable but not currently curable; management focuses on inducing and maintaining remission to prevent complications and preserve bowel length.

500+Gut Patients Treated
AvailableOnline Consultation
Take Gut Assessment

What Crohn's Disease Actually Is

Crohn's disease is a chronic inflammatory bowel disease in which the immune system attacks the gut in an inappropriate and self-sustaining way. The inflammation is transmural, meaning it penetrates through all layers of the gut wall, not just the inner lining. This is what distinguishes Crohn's from ulcerative colitis and makes it capable of producing structural complications like fistulas and strictures.

The pattern is also patchy. Unlike ulcerative colitis, which spreads continuously from the rectum, Crohn's appears in discrete segments with normal bowel in between, called skip lesions. It most commonly affects the terminal ileum (the last part of the small bowel) and the colon, but it can appear anywhere from mouth to anus.

The disease course varies. Some patients have prolonged remissions with occasional flares. Others have more continuously active disease. Some develop complications relatively early. Predicting the course in an individual patient is not straightforward, which is one reason monitoring and regular review matter even in stable Crohn's.

The Incidence Problem in India

IBD, including Crohn's disease, was historically considered rare in India. This is changing. Incidence has risen sharply over the past two decades, attributed to urbanisation, dietary changes, changes in early-life microbial exposure, and reduced physical activity. Many of these cases are initially misdiagnosed as IBS, infectious diarrhoea, or tuberculosis of the gut (which can look similar on imaging). The diagnostic delay is often measured in years.

Symptoms by Pattern and Location

Symptoms depend partly on which part of the gut is affected. The most common presentation involves the terminal ileum and right colon, producing right lower abdominal pain (often mimicking appendicitis in acute presentations), diarrhoea with or without blood, and systemic features of active inflammation.

Abdominal pain
Usually in the right lower abdomen over the terminal ileum. Cramping, colicky, often worse after eating or before bowel movements. Can be severe during flares.
Diarrhoea
Persistent, can include blood or mucus. Nocturnal diarrhoea that wakes the patient is a red flag distinguishing IBD from IBS.
Weight loss and fatigue
Disproportionate to apparent gut symptoms. Driven by malabsorption, reduced appetite, and the metabolic cost of chronic inflammation.
Perianal disease
Fistulas, abscesses, and persistent fissures around the anus in about 30% of patients. Can be the presenting feature before bowel symptoms are prominent.
Mouth ulcers
Aphthous ulcers in the mouth, often recurrent, are a recognised extra-intestinal feature of Crohn's.
Joint and skin symptoms
Peripheral arthritis (large joints, asymmetric), erythema nodosum (painful red skin nodules), and eye inflammation (uveitis, episcleritis) occur in 20-30% of patients.

The Complication Picture

Complications are a direct consequence of untreated or poorly controlled transmural inflammation. Strictures form where repeated cycles of inflammation and healing produce fibrosis and narrowing. A strictured bowel segment can cause obstructive symptoms: pain, bloating, nausea, and vomiting after eating, with the patient often reducing food intake to avoid symptoms.

Fistulas develop when inflammation penetrates through the gut wall to an adjacent organ or the skin surface. Enteroenteric fistulas (bowel to bowel) can cause malabsorption and diarrhoea. Enterovesical fistulas (bowel to bladder) cause urinary tract infections and air in the urine. Perianal fistulas are among the most difficult complications to manage, often requiring combined surgical and medical treatment.

Abscesses form adjacent to inflamed bowel and require drainage, sometimes surgically. Malnutrition develops when malabsorption and reduced oral intake go uncorrected. Terminal ileum disease specifically causes deficiency of vitamin B12 and fat-soluble vitamins (A, D, E, K), because absorption of these nutrients is localised to that segment.

How Crohn's is Distinguished from Intestinal Tuberculosis

In India, intestinal tuberculosis (ITB) is an important differential diagnosis for Crohn's disease because both affect the terminal ileum and right colon, both produce granulomas on biopsy, and both cause abdominal pain, diarrhoea, and weight loss. Getting this distinction right is essential: starting immunosuppressants for what turns out to be tuberculosis is dangerous.

Features favouring ITB over Crohn's include: TB exposure history or known pulmonary TB, positive Mantoux or IGRA (TB blood test), characteristic chest X-ray, ileocaecal valve involvement with a gaping patulous valve (rather than the tight strictured valve more common in Crohn's), and caseating granulomas on biopsy (Crohn's granulomas are non-caseating). In genuinely ambiguous cases, a therapeutic trial of anti-TB treatment before committing to immunosuppression is a reasonable approach.

Free Tool

Concerned About Inflammatory Bowel Disease?

Take our free gut health assessment: 15 questions, under 4 minutes. Get a personalised report on whether your symptoms warrant investigation for Crohn's disease or IBD.

  • ✓ Free assessment
  • ✓ Personalised risk report
  • ✓ No login required
🩺
Gut Health Assessment
15 questions · Under 4 minutes
Take Free Assessment →

No credit card. No spam. Just your personalised report.

Patient Story

A Real Recovery Story

"

Arjun had abdominal pain and diarrhoea on and off for three years. He'd lost 8 kg without trying to, and had been managing with dietary changes alone. A flare with severe pain and blood in his stool finally prompted investigation. Ileocolonoscopy showed transmural inflammation in the terminal ileum with the classic cobblestone appearance of Crohn's. Calprotectin was 1,200. MRI showed no strictures yet. Appropriate medical treatment brought him into remission within 12 weeks. He regained weight, symptoms resolved, and he now has a management plan that monitors for complications rather than waiting for them to happen."

A
Arjun P.
Patient · Kolkata · treated at HomeoSure
★★★★★
Common Questions

Frequently Asked Questions: Crohn's Disease

Early Crohn's can be subtle and often gets dismissed or misdiagnosed. The most common early presentation is recurring abdominal pain, typically in the right lower abdomen over the terminal ileum, often coming on after eating or with bowel movements. Diarrhoea is common, and unlike IBS, it may continue at night and can include blood or mucus. Weight loss and fatigue that seem disproportionate to gut symptoms are significant early features. Some patients notice mouth ulcers (aphthous ulcers), which are a recognised extra-intestinal feature of Crohn's. Perianal symptoms, including fissures, skin tags, and fistulas near the anus, appear in a subset of patients and can precede the bowel diagnosis by years. Fever during symptomatic periods suggests active inflammation.
Crohn's is an immune-mediated condition in which the gut immune system mounts an inappropriate inflammatory response against normal gut contents, probably triggered in a genetically susceptible person by environmental factors. Genetics play a role: around 200 gene variants have been identified that increase Crohn's risk, with the NOD2/CARD15 gene being the most studied. But genetics alone are not sufficient, because the majority of identical twins are discordant for Crohn's (only one twin has it). Environmental factors include smoking (significantly increases Crohn's risk, distinct from ulcerative colitis where smoking is paradoxically protective), disruption of the gut microbiome in early life, use of antibiotics in childhood, dietary patterns (Western diet, low in fibre, high in processed foods), and possibly appendicectomy. Stress does not cause Crohn's but can trigger flares in established disease.
Diagnosis requires combining clinical assessment, blood tests, stool tests, endoscopy, and imaging. Blood tests may show elevated CRP, raised white cell count, and anaemia. Faecal calprotectin is typically markedly elevated in active Crohn's (often above 500 micrograms per gram). Ileocolonoscopy with biopsies from multiple sites is the central investigation: it directly visualises the colon and terminal ileum, identifies the characteristic patchy inflammation and skip lesions, and allows biopsy for histological confirmation showing granulomas in around 30 percent of cases. Because Crohn's can affect the small bowel proximal to what colonoscopy can reach, MRI enterography or CT enterography is often added to assess the small intestine. Capsule endoscopy is used in selected cases.
Complications arise from the transmural (full-thickness) nature of Crohn's inflammation, which IBS and even ulcerative colitis do not produce in the same way. Intestinal strictures develop where fibrosis follows repeated inflammation, causing narrowing that can lead to obstruction. Fistulas form when inflammation penetrates through the gut wall and creates abnormal channels to adjacent organs: between loops of bowel (enteroenteric), to the bladder (enterovesical), skin (enterocutaneous), or vagina. Perianal disease, including fistulas, abscesses, and chronic fissures, affects about 30 percent of Crohn's patients and can be significantly disabling. Abscesses form around inflamed gut segments. Nutritional deficiencies, particularly iron, B12 (if the terminal ileum is affected), zinc, and fat-soluble vitamins, are common. Around 70-80 percent of Crohn's patients require surgery at some point in their lifetime.
Both are forms of IBD but have different patterns. Crohn's can affect any part of the GI tract from mouth to anus, shows patchy skip lesions, and involves the full thickness of the gut wall (transmural). Ulcerative colitis is confined to the colon, always involves the rectum, and spreads continuously upward, affecting only the innermost mucosal layer. Rectal bleeding is more prominent in ulcerative colitis. Small bowel involvement, perianal disease, and fistulas are features of Crohn's not seen in ulcerative colitis. The risk of surgery differs: colectomy in ulcerative colitis can be curative, while surgery in Crohn's removes affected segments but does not cure the disease. Some patients have an indeterminate pattern, particularly when only the colon is affected, that cannot be definitively classified as Crohn's or ulcerative colitis on initial investigation.
Currently, Crohn's disease cannot be permanently cured. But remission, meaning the complete absence of active inflammation, is achievable and maintainable in most patients with appropriate treatment. Medical therapy can induce and sustain remission, protect the gut from structural damage, prevent complications, and allow normal function and quality of life. Treatment has advanced significantly over the past 20 years, particularly with biological therapies targeting specific inflammatory pathways. The goal of modern Crohn's management is deep remission: resolution of symptoms plus mucosal healing on endoscopy, not just symptom control. Patients who achieve mucosal healing have substantially lower rates of complications, hospitalisation, and surgery. Regular monitoring, even in remission, is part of long-term management.

Gut symptoms that have never been properly investigated?

Crohn's disease progresses over time when untreated, with complications accumulating before they are diagnosed. If your gut symptoms include pain, diarrhoea, weight loss, or blood, a structured assessment and appropriate investigation is the right starting point.

  • ✓ Detailed first consultation
  • ✓ In-clinic and online options available
  • ✓ Replies within 2-4 hours on WhatsApp
Book a Consultation

We respect your privacy. Your details are never shared.